ScienceDaily (Jan. 8, 2009) — Mice exposed to low temperatures develop more blood vessels in their adipose tissue and metabolise body fat more quickly, according to a new study from Karolinska Institutet. Scientists now hope to learn how to control ...
Read more...
Joslin Diabetes Center today announced it has received a $1 million gift from the Thomas Beatson Jr. Foundation to support Type 1 diabetes research. The donation will be split evenly between the labs of Joslin research doctors T. Keith Blackwell ...
Read more...
(RTTNews) - Orexigen Therapeutics Inc. (OREX: News ), Thursday announced that the first of four phase 3 trials of its lead investigational product Contrave met its co-primary and key secondary endpoints, showing a significant reduction in body weight ...
Read more...
DALLAS, Jan 9 (Reuters) - Americans may reduce the amount they spend on food in response to a sour economy but some experts fear they may pick up weight in the process. The specter of "recession pounds" is a concern weighing on health professionals ...
Read more...
LOS ALTOS, Calif., Jan. 8 /PRNewswire/ -- InteKrin Therapeutics, Inc., will present at the 27th Annual JP Morgan Global Healthcare Conference at 9:00 a.m. Pacific Time on Tuesday, January 13, 2009, to be held at the Westin St. Francis in San ...
Read more...
Obesity patients treated with a weight-loss pill from Orexigen Therapeutics ( OREX Quote - Cramer on OREX - Stock Picks ) lost an average of 20.3 pounds, or 9.3% of their body weight, over one year, according to results from a phase III study ...
Read more...
Diamyd Medical AB (publ.) (Pink Sheets:DMYDY) (STO:DIAMB): A renowned research group at Lund University has filed an application with the Swedish Medical Products Agency to carry out a study of the diabetes vaccine Diamyd® for the prevention of type ...
Read more...